Tumor heterogeneity measurement using [18F] FDG PET/CT shows prognostic value in patients with non-small cell lung cancer

Por N. M. Hughes, T. Mou, K. N. O’Regan, P. Murphy, J. N. O’Sullivan, E. Wolsztynski, J. Huang, M. P. Kennedy, J. F. Eary, F. O’Sullivan
Publicado em 2018-12-01